Clinical Evaluation of a Toothpaste for Dental Plaque Reduction and Prevention of Gum Problems
Clinical Evaluation of a Stannous Fluoride Toothpaste Versus a 67% Bicarbonate Toothpaste and Colgate Cavity Protection Toothpaste for Dental Plaque Reduction and Prevention of Gum Problems: a Six-month Clinical Study in Italy
Qualified subjects will be enrolled and randomized to either one of the three study groups described above based on their initial modified gingivitis and plaque scores. Subjects will be instructed to use the products according to the instructions provided. Subjects will return to the dental office for evaluation after three months and six months of product use. All subjects will be followed for adverse events throughout the study.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Fase 3
Kontakter og lokationer
Studiekontakt
- Navn: Luigi Montensani, DDS
- Telefonnummer: +39-338-6187383;
- E-mail: luigi@montensani.it
Studiesteder
-
-
Rome
-
Roma, Rome, Italien, 00187
- Rekruttering
- Clinica Odontoiatrica Montesani
-
Kontakt:
- Luigi Montesani, MD, DDS
- Telefonnummer: +39-338-6187383
- E-mail: luigi@montesani.it
-
Ledende efterforsker:
- Luigi Montesani, MD, DDS
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Subjects, ages 18-70, inclusive.
- Availability for the six-month duration of the study.
- Good general health.
- Initial gingivitis index of at least 1.5 as determined by the use of the Modified Gingivitis Index.
- Initial plaque index of at least 1.5 as determined by the use of the Modified Quigley-Hein Plaque Index.
- Signed Informed Consent Form
Exclusion Criteria:
- Orthodontic bands.
- Tumor(s) of the soft or hard tissues of the oral cavity.
- Advanced periodontal disease (purulent exudate, tooth mobility), and/or
- Extensive loss of periodontal attachment or alveolar bone.
- Five or more carious lesions requiring immediate restorative treatment
- Use of antibiotics any time during the one month prior to entry into the study.
- Participation in any other clinical study or test panel within the one month prior to entry into the study.
- Received a dental prophylaxis in the two weeks prior to your initial examination.
- History of allergies to oral care/personal care consumer products or their ingredients.
- Having taken any prescription medicines that might interfere with the study outcome.
- If you with an existing medical condition which prohibits you from not eating or drinking for periods of up to 4 hours.
- Self-reported pregnant or breast feeding an infant.
- History of drug abuse
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Test 1 toothpaste
Approximately, 1.5 grams (full ribbon covering the head of toothbrush) of toothpaste shall be used for each brushing, 2 times daily (morning and evening) for 2 minutes each time |
toothpaste |
|
Aktiv komparator: Positive Control
Approximately, 1.5 grams (full ribbon covering the head of toothbrush) of toothpaste shall be used for each brushing, 2 times daily (morning and evening) for 2 minutes each time |
toothpaste |
|
Aktiv komparator: Negative Control
Approximately, 1.5 grams (full ribbon covering the head of toothbrush) of toothpaste shall be used for each brushing, 2 times daily (morning and evening) for 2 minutes each time |
Toothpaste with MFP/NaF (1450 F) |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Lobene Modified Gingivitis Assessment
Tidsramme: Baseline, 3 month, 6 month
|
Modified Gingivitis Index score from 0 to 4 will be assigned by the examining dentist to all tooth surfaces using a dental light and dental mirror. A whole mouth mean score for each subject will be determined by adding the values given by the examining dentist to each scoreable surface and dividing that number by the total number of surfaces scored |
Baseline, 3 month, 6 month
|
|
Saxton Gingival Bleeding Assessment
Tidsramme: Baseline, 3 month, 6 month
|
Gingival bleeding is assessed 30 seconds after probing; a score of 0 represents an absence of bleeding, a score of 1 is given if bleeding is observed within 30 seconds after probing and a score of 2 is given if bleeding is observed immediately on probing |
Baseline, 3 month, 6 month
|
|
Modified Quigley-Hein Plaque Index
Tidsramme: Baseline, 3 month, 6 month
|
First using a red dye solution to disclose the plaque, a Modified Quigley-Hein Plaque Index score of 0 to 5 will be assigned to all scoreable disclosed tooth surfaces using a dental light and dental mirror. A whole mouth score for each subject will be determined by adding the values given by the dental examiner to each scoreable surface and dividing that number by the total number of surfaces scored. |
Baseline, 3 month, 6 month
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Luigi Montensani, DDS, Clinica Odontoiatrica Montesani
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Periodontale sygdomme
- Mundsygdomme
- Stomatognatiske sygdomme
- Patologiske Tilstande, Anatomiske
- Tandsygdomme
- Infektioner
- Gingival sygdomme
- Tandindskud
- Patologiske tilstande, tegn og symptomer
- Tandplak
- Plaque, Amyloid
- Gingivitis
- Uorganiske kemikalier
- Anioner
- Ioner
- Elektrolytter
- Carbonforbindelser, uorganisk
- Carbonater
- Kulsyre
- Bicarbonater
Andre undersøgelses-id-numre
- CRO-2026-07-PGN-GAD-ITA-YPZ
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .